Literature DB >> 12779042

Nasopharyngeal lymphoid hyperplasia of an HIV carrier, mimicking nasopharyngeal cancer.

Mao-Che Wang1, Tung-Lung Tsai, Chia-Yu Liu, Chih-Hung Shu, Ching-Zong Lin.   

Abstract

Lymphoid hyperplasia of cervical lymph nodes is a common head and neck presentation of human immunodeficiency virus (HIV) infection. Lymphoid hyperplasia of HIV carrier presenting as nasopharyngeal tumor and neck mass is rarely discussed. We reported a 30-year-old male patient who had left side neck mass for 3 months. Nasopharyngeal cancer with neck metastasis was impressed due to huge nasopharyngeal tumor and neck mass. The patient was then transferred to our clinic for further evaluation. Physical examination revealed a 30 x 30 mm mass over left jugulodigastric area and a 20 x 20 mm mass over left posterior triangle of neck. Telescopic examination revealed a 20 x 20 mm bulging mass over nasopharynx. Nasopharyngeal biopsy was done and histopathologic examination revealed lymphoid hyperplasia. Laboratory survey showed seropositive of HIV infection for both enzyme-linked immunosorbent assay (ELISA) and western blot tests.

Entities:  

Mesh:

Year:  2003        PMID: 12779042

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  2 in total

1.  Hypertrophic adenoids in patients with nasopharyngeal carcinoma: appearance at magnetic resonance imaging before and after treatment.

Authors:  Yao-Pan Wu; Pei-Qiang Cai; Li Tian; Jie-Hua Xu; Richard Alan Mitteer; Yi Fan; Zhenfeng Zhang
Journal:  Chin J Cancer       Date:  2015-03-05

2.  Pathological manifestations of feline immunodeficiency virus (FIV) infection in wild African lions.

Authors:  Melody E Roelke; Meredith A Brown; Jennifer L Troyer; Hanlie Winterbach; Christiaan Winterbach; Graham Hemson; Dahlem Smith; Randall C Johnson; Jill Pecon-Slattery; Alfred L Roca; Kathleen A Alexander; Lin Klein; Paolo Martelli; Karthiyani Krishnasamy; Stephen J O'Brien
Journal:  Virology       Date:  2009-05-22       Impact factor: 3.616

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.